Harriet Wylie

Harriet is a Trial Coordinator who supports the portfolio of Urology and Oncology studies run by the TOUR team. She has been involved in the set-up and delivery of two Movember funded multi-site studies, for which we are the lead UK site. These include INTERVAL, an exercise intervention trial in metastatic prostate cancer patients, and IRONMAN, a global registry study for men with advanced prostate cancer. She is also involved in the screening and recruiting of Urology and Oncology prostate and bladder cancer patients for the King's Health Partners' Biobank, and assists the wider TOUR team with administrative support and patient and public engagement.